Lipid Nanoparticles in Lung Cancer Therapy
This manuscript explores the use of lipid nanoparticles (LNPs) in addressing the pivotal challenges of lung cancer treatment, including drug delivery inefficacy and multi-drug resistance. LNPs have significantly advanced targeted therapy by improving the precision and reducing the systemic toxicity...
Saved in:
Main Authors: | Hossein Omidian (Author), Erma J. Gill (Author), Luigi X. Cubeddu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chitosan Nanoparticles for Intranasal Drug Delivery
by: Hossein Omidian, et al.
Published: (2024) -
Nanosystems in Cardiovascular Medicine: Advancements, Applications, and Future Perspectives
by: Hossein Omidian, et al.
Published: (2023) -
Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles
by: Liu J, et al.
Published: (2018) -
Overview of Solid Lipid Nanoparticles in Breast Cancer Therapy
by: Kyumin Mo, et al.
Published: (2023) -
Hybrid Magnetic Lipid-Based Nanoparticles for Cancer Therapy
by: Marcela Tavares Luiz, et al.
Published: (2023)